Premium
Combined liver and lung metastasectomy through an exclusive transthoracic approach
Author(s) -
Delis Spiros G.,
Madariaga Juan,
Bakoyiannis Andreas,
Avgerinos Costas,
Touloumis Zisis,
Vasileios Vasiliadis,
Dervenis Christos
Publication year - 2007
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.20723
Subject(s) - medicine , metastasectomy , pleural effusion , lung , surgery , pneumonia , effusion , metastasis , radiology , cancer
Background In a very selected group of patients, resection of metachronous liver and lung metastases, prolongs survival despite the aggressive nature of these lesions. We present here our experience with metastasectomy in patients with metachronous liver and lung metastases in whom, an exclusive transthoracic approach was performed. Methods Between 2002 and 2005, five patients with metachronous colorectal liver and right‐lung metastases, underwent an exclusive transthoracic approach. There were three men and two women, with a median age of 68 years (range, 55–76 years). Liver resections performed included segmentectomy of segments VII, VIII, or both. Previous operations include colon resection, adhesiolysis, or ventral hernia repair were performed in all patients. Results No mortality was documented. Morbidity included pleural effusion (n = 2) and post‐operative pneumonia (n = 1) which responded to conservative management. Median hospital stay was 8 days (range 5–12 days). With a median follow‐up of 26 months all patients are alive without recurrent disease. Conclusion An aggressive surgical approach should be undertaken for CRC metastases. An exclusive transthoracic approach is feasible for combined lung and subdiaphragmatic liver metastasectomy in selected cases with previous abdominal surgery. J. Surg. Oncol. 2007;96:178–182. © 2007 Wiley‐Liss, Inc.